Monday, 15 February 2016

NEJM Week of 28th January 2016 (#27)


Professor Brian Andrews NEJM Recommendations for Medical Students and Tutors
Week of the 28th January 2016 (#27)
University of Notre Dame Australia
(Fremantle Campus)

Occasional Editorial Comment
None

Must Read Section
IMAGES IN CLINICAL MEDICINE

Cannon A Waves

http://www.nejm.org/doi/full/10.1056/NEJMicm1413235

A 65-year-old man presented with an abrupt onset of heart palpitations and dyspnea during the previous hour. He had had three similar episodes but had no other known conditions. Examination of the jugular venous pulsation revealed cannon atrial waves, shown in a video.

 

This video should be reviewed by all readers of the blob, but particularly medical students doing clinical skills or examining patients.

 

Recommended learning: Review all of the information you can learn from the jugular venous pulse and relate these to pathology and the cardiac cycle.


Articles Recommended for Medical Students
Perspective

Opioid Prescribing for Chronic Pain — Achieving the Right Balance through Education

Groups advocating quick fixes to the opioid-misuse epidemic seek regulations limiting opioid availability, but prescriber education is a more finely tuned approach, allowing us to individualize care appropriately after a careful benefit–risk assessment.

This Perspective emphasises the importance of education in the role of prescribing opioids for the management of chronic pain and how important it is to educate medical students, interns and residents in their appropriate use.

Question: For how long, and should, over the counter (OTC) codeine remain available in Australia?


IMAGES IN CLINICAL MEDICINE

Primary and Secondary Syphilis

A previously healthy 68-year-old man presented with a solid erosive sore on the inside of his upper lip. He also had sharply demarcated erythematous, scaly plaques on his hands and feet, including the palms and soles. The lesions had been present for over a year.

In most patients, primary syphilis is represented by a chancre which can occasionally last up to 6 weeks. The lesion in the mouth of this patient is not the typical “snail track ulcer seen in secondary syphilis, although the presence of the rash is typical, especially the palm and sole involvement. This is NOT a typical presentation with both primary and secondary disease present.

Recommended learning: Review the prevalence of syphilis in Australia, the association with HIV infection, the pathology and clinical presentations of the various stages and the management. Contrast the presentations of syphilis with the stages of Lyme disease.

CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL
Case 3-2016 — A 9-Year-Old Girl with Intermittent Abdominal Pain

A 9-year-old girl with chronic constipation was seen in the gastroenterology clinic because of increasingly frequent episodes of abdominal pain with associated non-bilious vomiting. A diagnosis was made

There is an interesting discussion of abdominal pain in a 9 year old girl from the perspectives of both the GP/paediatrician and the gastroenterologist. The diagnosis however is unexpected.

Recommended learning: Abdominal pain in the paediatric patient


Important Articles Related to Mechanisms of Disease and Translational Research

None

Other areas which should be of interest to medical students

EDITORIAL

Progress in Chronic Lymphocytic Leukemia with Targeted Therapy


This Editorial summarizes the results of two articles in this week’s Journal which describe two second-generation therapies (i.e. an improvement on first generation therapy and are usually more selective in targeting and with fewer adverse events) used to treat relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma. These newer agents basically inhibit intracellular B-cell receptor signalling and induce apoptosis. The first drug (venetoclax – don’t even try to remember any new drug names, just try to understand the mechanism of action) works by selectively targeting the anti-apoptotic protein BCL2 thus rendering the cell more susceptible to apoptosis. The second drug, acalabrutinib, i) irreversibly inhibits the Bruton’s tyrosine kinase (BTK), which is immediately downstream from the B-cell receptor, and thus blocks activation and additionally, ii) BTK is involved in chemokine-mediated homing and adhesion of CLL cells to the microenvironment which are responsible indirectly for cell preservation and proliferation.

Recommended learning: Biology of apoptosis and B-cell activation and signalling.

ORIGINAL ARTICLE

Belatacept and Long-Term Outcomes in Kidney Transplantation


This study evaluated the 7-year efficacy and safety outcomes in transplant recipients assigned to a more-intensive or less-intensive belatacept regimen or a standard cyclosporine for immunosuppression. Both belatacept regimens were associated with significantly superior patient and graft survival.


EDITORIAL

The Clearer BENEFITS of Belatacept


This article and Editorial address patient and renal allograft survival in patients 7 years after transplantation with chronic anti-graft immunosuppression by either high or lower dose belatacept compared with standard dose cyclosporine (a calcineurin inhibitor). Belatacept is similar to abatacept, a monoclonal antibody used in the treatment of RA.  The antibody is a fusion protein containing the Fc fragment of human IgG1 to maintain the T/2 of the antibody and CTLA4 (cytotoxic T-lymphocyte antigen 4) which blocks co-stimulatory T cell activation signals. The results (see Kaplan-Meier curves for patient and graft survival- Figure 2 and Figure 3 for mean eGFR) indicate that for both doses of the monoclonal antibody, patient and graft survival and eGFR at 7 years are superior to cyclosporine therapy. Cumulative adverse events are similar with all therapies.

Recommended learning:
i)              Pathways and receptors involved in T lymphocyte activation.
ii)             How are therapeutic monoclonal antibodies produced?


REVIEW ARTICLE

Neurobiologic Advances from the Brain Disease Model of Addiction

The neurobiology of addiction is pointing the way to potential methods of disrupting the neurocircuitry with both pharmaceutical and behavioral tools. Altering the reward and emotional circuits may prevent and treat the problem.


This Review article considers the scientific advances in the prevention and treatment of substance-abuse disorder and related developments in public policy in the US. It discusses the prevalence of addiction, the stages of addiction and the biological and social factors involved in addiction. There is an interesting Figure 1 describing the neurobiology of the stages of addiction.


I would consider reading this review prior to a clinical rotation in Addiction Medicine, prior to the Psychiatry rotation in MED400 or if you have a specific interest in this area.